Market Place
Sourcing Support
Zealand Pharma: Managerial Transactions in Shares, Securities
10 Jun 2026 //
GLOBENEWSWIRE
Zealand Pharma Drops 25% as Patients Quit Obesity Drug Trial
08 Jun 2026 //
REUTERS
Zealand Pharma Raises Share Capital via Employee Warrant Exercise
08 Jun 2026 //
GLOBENEWSWIRE
Zealand Pharma Executes Share Buy-Back Transactions in Week 23
08 Jun 2026 //
GLOBENEWSWIRE
Survodutide Cuts Visceral Fat 34%, Liver Fat 63% in Ph III Trial
07 Jun 2026 //
PRESS RELEASE
ZUPREME-1 Ph2 Data Back Petrelintide for Weight Management at ADA
05 Jun 2026 //
GLOBENEWSWIRE
Zealand Pharma to Present at Goldman Sachs Healthcare Conference
02 Jun 2026 //
GLOBENEWSWIRE
Zealand Pharma Initiates Share Buy-Back Program In Week 22, 2026
01 Jun 2026 //
GLOBENEWSWIRE
Zealand Pharma Discloses Share Transactions by Managers
29 May 2026 //
GLOBENEWSWIRE
Zealand Pharma to Present Data at ADA 2026
27 May 2026 //
GLOBENEWSWIRE
Zealand Pharma to Attend Jefferies Global Healthcare Conference
27 May 2026 //
GLOBENEWSWIRE
Zealand Pharma - Transactions Related to Share Buy-Back Program
26 May 2026 //
GLOBENEWSWIRE
Zealand Pharma Passes Extraordinary General Meeting Resolutions
26 May 2026 //
GLOBENEWSWIRE
Zealand Pharma Discloses Share Buy-Back Activity (WK 19-20)
14 May 2026 //
GLOBENEWSWIRE
Zealand Pharma to Hold EGM on May 26
01 May 2026 //
GLOBENEWSWIRE
Zealand Pharma Board Proposes Camilla Sylvest For Director Role
01 May 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present Q1 2026 Financial Results
30 Apr 2026 //
GLOBENEWSWIRE
Zealand, Roche Advance Petrelintide Amylin to Phase 3
29 Apr 2026 //
FIRSTWORD PHARMA
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Zealand Pharma Reveals Boehringer`s Dual Agonist Survodutide
28 Apr 2026 //
GLOBENEWSWIRE
Roche Backs Amylin Drug for Low-Side-Effect Obesity Care
23 Apr 2026 //
BIOSPACE
Zealand Pharma Launches 2026 LTI Program for Board and Management
19 Apr 2026 //
FIRSTWORD PHARMA
Zealand Pharma Insiders Trade Shares, Securities
19 Apr 2026 //
GLOBENEWSWIRE
Zealand Pharma Names Eric Rojas Vp, Head Of Investor Relations
14 Apr 2026 //
GLOBENEWSWIRE
Zealand Pharma Updates Shares and Voting Rights as of March 31
31 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma`s 2026 AGM Resolutions
26 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Sets Up U.S. Research Hub In Cambridge, MA
24 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Boosts Share Capital Through Employee Warrant
19 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present At March 2026 Investor Conferences
09 Mar 2026 //
GLOBENEWSWIRE
Zealand`s Zupreme serves up to 10.7% mean weight loss
06 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results For The Full Year 2025
19 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma convenes its Annual General Meeting 2026
19 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma: Positive Phase 1a Data for ZP9830
18 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma Sets Feb. 19 Call on 2025 Results
12 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma Utilizes Danish Supercomputer For Drug Discovery
14 Jan 2026 //
INDPHARMAPOST
Zealand Pharma Partners With DCAI For Gefion AI Supercomputer
09 Jan 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present At J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Zealand Pharma Reports Shares, Voting Rights as of Dec. 31, 2025
31 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Managers Engage In Share Transactions
19 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Unveils Metabolic Frontier 2030 Strategy
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma, OTR Therapeutics Ink Metabolic Collaboration
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Boosts Share Capital Through Employee Warrant
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma to Accelerate Drug Development for obesity
11 Dec 2025 //
REUTERS
Zealand Pharma Managers Engage In Share Transactions
05 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma To Host Capital Markets Day On Dec 11, 2025
01 Dec 2025 //
GLOBENEWSWIRE
Zealand Pumps Brakes On Development Of Dual GLP-1/GLP-2 Agonist
13 Nov 2025 //
FIERCE BIOTECH
Zealand Pharma To Join Jefferies Global Healthcare Conference
12 Nov 2025 //
GLOBENEWSWIRE
Zealand Pharma To Present Q3 2025 Financial Results
06 Nov 2025 //
GLOBENEWSWIRE
Van Herk Investments B.V. Reveals Stake In Zealand Pharma
17 Oct 2025 //
GLOBENEWSWIRE
Zealand Pharma: Shares & Voting Rights As Of Sept 30, 2025
30 Sep 2025 //
GLOBENEWSWIRE
Zealand Pharma May Sell Future Obesity Drug Direct to Patients
23 Sep 2025 //
REUTERS
Zealand Pharma`s Capital Markets Day in London, Dec 11, 2025
11 Sep 2025 //
GLOBENEWSWIRE
Zealand Pharma Boost Share Capital via Employee Warrants Exercise
11 Sep 2025 //
GLOBENEWSWIRE
Zealand Pharma to Present at September 2025 Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Zealand Announces Major Shareholder: Van Herk Investments B.V.
20 Aug 2025 //
GLOBENEWSWIRE
Zealand Pharma reports first-half 2025 financial results
14 Aug 2025 //
GLOBENEWSWIRE
Zealand Pharma to Present Q2 2025 Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Van Herk Investments B.V. Announces Major Stake in Zealand Pharma
18 Jul 2025 //
GLOBENEWSWIRE
Zealand Pharma`s Shares and Voting Rights as of June 30, 2025
30 Jun 2025 //
GLOBENEWSWIRE
Zealand`s Dual Agonist Tied to 11% Weight Loss in Phase 1b
20 Jun 2025 //
FIERCE BIOTECH
